A citation-based method for searching scientific literature

John M Carethers, E Julieta Smith, Cynthia A Behling, Lanchinh Nguyen, Akihiro Tajima, Ryan T Doctolero, Betty L Cabrera, Ajay Goel, Christian A Arnold, Katsumi Miyai, C Richard Boland. Gastroenterology 2004
Times Cited: 346







List of co-cited articles
898 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
Christine M Ribic, Daniel J Sargent, Malcolm J Moore, Stephen N Thibodeau, Amy J French, Richard M Goldberg, Stanley R Hamilton, Pierre Laurent-Puig, Robert Gryfe, Lois E Shepherd,[...]. N Engl J Med 2003
60

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
40

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, Stephen N Thibodeau, Roberto Labianca, Stanley R Hamilton, Amy J French, Brian Kabat, Nathan R Foster, Valter Torri,[...]. J Clin Oncol 2010
975
33



A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C R Boland, S N Thibodeau, S R Hamilton, D Sidransky, J R Eshleman, R W Burt, S J Meltzer, M A Rodriguez-Bigas, R Fodde, G N Ranzani,[...]. Cancer Res 1998
22

Microsatellite instability in colorectal cancer.
C Richard Boland, Ajay Goel. Gastroenterology 2010
20

Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
R Jover, P Zapater, A Castells, X Llor, M Andreu, J Cubiella, V Piñol, R M Xicola, L Bujanda, J M Reñé,[...]. Gut 2006
171
18

DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Frank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, Silvia Marsoni, Genevieve Monges, Roberto Labianca, George P Kim, Greg Yothers, Carmen Allegra, Malcolm J Moore,[...]. J Natl Cancer Inst 2011
348
18

Genomic and epigenetic instability in colorectal cancer pathogenesis.
William M Grady, John M Carethers. Gastroenterology 2008
623
17

Microsatellite instability and colorectal cancer prognosis.
Piero Benatti, Roberta Gafà, Daniela Barana, Massimiliano Marino, Alessandra Scarselli, Monica Pedroni, Iva Maestri, Laura Guerzoni, Luca Roncucci, Mirco Menigatti,[...]. Clin Cancer Res 2005
273
16

The consensus molecular subtypes of colorectal cancer.
Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurélien de Reyniès, Andreas Schlicker, Charlotte Soneson, Laetitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino,[...]. Nat Med 2015
16

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
15

The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance.
Akihiro Tajima, Martin T Hess, Betty L Cabrera, Richard D Kolodner, John M Carethers. Gastroenterology 2004
107
15

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
15

The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.
Rodrigo Jover, Pedro Zapater, Antoni Castells, Xavier Llor, Montserrat Andreu, Joaquín Cubiella, Francesc Balaguer, Laura Sempere, Rosa M Xicola, Luis Bujanda,[...]. Eur J Cancer 2009
148
13

Association between molecular subtypes of colorectal cancer and patient survival.
Amanda I Phipps, Paul J Limburg, John A Baron, Andrea N Burnett-Hartman, Daniel J Weisenberger, Peter W Laird, Frank A Sinicrope, Christophe Rosty, Daniel D Buchanan, John D Potter,[...]. Gastroenterology 2015
276
12

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Hidewaki Nakagawa, Kaisa Sotamaa, Thomas W Prior, Judith Westman,[...]. N Engl J Med 2005
958
12

DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells.
Moriya Iwaizumi, Stephanie Tseng-Rogenski, John M Carethers. Cancer Biol Ther 2011
34
35

Both hMutSα and hMutSß DNA mismatch repair complexes participate in 5-fluorouracil cytotoxicity.
Akihiro Tajima, Moriya Iwaizumi, Stephanie Tseng-Rogenski, Betty L Cabrera, John M Carethers. PLoS One 2011
28
42

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.
R Gryfe, H Kim, E T Hsieh, M D Aronson, E J Holowaty, S B Bull, M Redston, S Gallinger. N Engl J Med 2000
12

Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.
Sabine Venderbosch, Iris D Nagtegaal, Tim S Maughan, Christopher G Smith, Jeremy P Cheadle, David Fisher, Richard Kaplan, Philip Quirke, Matthew T Seymour, Susan D Richman,[...]. Clin Cancer Res 2014
382
12

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.
Michael J Overman, Ray McDermott, Joseph L Leach, Sara Lonardi, Heinz-Josef Lenz, Michael A Morse, Jayesh Desai, Andrew Hill, Michael Axelson, Rebecca A Moss,[...]. Lancet Oncol 2017
12

Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.
Cecilia Guastadisegni, Mauro Colafranceschi, Laura Ottini, Eugenia Dogliotti. Eur J Cancer 2010
264
11

Microsatellite instability in cancer of the proximal colon.
S N Thibodeau, G Bren, D Schaid. Science 1993
11

5-fluorouracil: mechanisms of action and clinical strategies.
Daniel B Longley, D Paul Harkin, Patrick G Johnston. Nat Rev Cancer 2003
11

Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.
John M Carethers, Barbara H Jung. Gastroenterology 2015
258
11

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
Nicolas J Llosa, Michael Cruise, Ada Tam, Elizabeth C Wicks, Elizabeth M Hechenbleikner, Janis M Taube, Richard L Blosser, Hongni Fan, Hao Wang, Brandon S Luber,[...]. Cancer Discov 2015
877
11

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.
Gordon Hutchins, Katie Southward, Kelly Handley, Laura Magill, Claire Beaumont, Jens Stahlschmidt, Susan Richman, Philip Chambers, Matthew Seymour, David Kerr,[...]. J Clin Oncol 2011
454
11

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Marta Zaninelli, Philip Clingan, John Bridgewater,[...]. N Engl J Med 2004
11

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
David Tougeron, Guillaume Mouillet, Isabelle Trouilloud, Thierry Lecomte, Romain Coriat, Thomas Aparicio, Gaetan Des Guetz, Cédric Lécaille, Pascal Artru, Gaelle Sickersen,[...]. J Natl Cancer Inst 2016
93
11

Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients.
Giovanni Lanza, Roberta Gafà, Alessandra Santini, Iva Maestri, Laura Guerzoni, Luigi Cavazzini. J Clin Oncol 2006
150
11

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11

Microsatellite instability in colorectal cancer-the stable evidence.
Eduardo Vilar, Stephen B Gruber. Nat Rev Clin Oncol 2010
492
10

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer.
Daniel J Weisenberger, Kimberly D Siegmund, Mihaela Campan, Joanne Young, Tiffany I Long, Mark A Faasse, Gyeong Hoon Kang, Martin Widschwendter, Deborah Weener, Daniel Buchanan,[...]. Nat Genet 2006
10

Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.
George P Kim, Linda H Colangelo, H Samuel Wieand, Soonmyung Paik, Ilan R Kirsch, Norman Wolmark, Carmen J Allegra. J Clin Oncol 2007
249
10

Relationship of EMAST and microsatellite instability among patients with rectal cancer.
Bikash Devaraj, Aaron Lee, Betty L Cabrera, Katsumi Miyai, Linda Luo, Sonia Ramamoorthy, Temitope Keku, Robert S Sandler, Kathleen L McGuire, John M Carethers. J Gastrointest Surg 2010
64
15


Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.
Noralane M Lindor, Lawrence J Burgart, Olga Leontovich, Richard M Goldberg, Julie M Cunningham, Daniel J Sargent, Catherine Walsh-Vockley, Gloria M Petersen, Michael D Walsh, Barbara A Leggett,[...]. J Clin Oncol 2002
593
10


Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
Yvette Schwitalle, Matthias Kloor, Susanne Eiermann, Michael Linnebacher, Peter Kienle, Hanns Peter Knaebel, Mirjam Tariverdian, Axel Benner, Magnus von Knebel Doeberitz. Gastroenterology 2008
243
10

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Jérôme Galon, Anne Costes, Fatima Sanchez-Cabo, Amos Kirilovsky, Bernhard Mlecnik, Christine Lagorce-Pagès, Marie Tosolini, Matthieu Camus, Anne Berger, Philippe Wind,[...]. Science 2006
10

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.
Arnaud D Roth, Sabine Tejpar, Mauro Delorenzi, Pu Yan, Roberto Fiocca, Dirk Klingbiel, Daniel Dietrich, Bart Biesmans, György Bodoky, Carlo Barone,[...]. J Clin Oncol 2010
842
10

Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Frank A Sinicrope, Qian Shi, Thomas C Smyrk, Stephen N Thibodeau, Rodrigo Dienstmann, Justin Guinney, Brian M Bot, Sabine Tejpar, Mauro Delorenzi, Richard M Goldberg,[...]. Gastroenterology 2015
218
9

CpG island methylator phenotype in colorectal cancer.
M Toyota, N Ahuja, M Ohe-Toyota, J G Herman, S B Baylin, J P Issa. Proc Natl Acad Sci U S A 1999
9

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
J G Herman, A Umar, K Polyak, J R Graff, N Ahuja, J P Issa, S Markowitz, J K Willson, S R Hamilton, K W Kinzler,[...]. Proc Natl Acad Sci U S A 1998
9

Mismatch repair proficiency and in vitro response to 5-fluorouracil.
J M Carethers, D P Chauhan, D Fink, S Nebel, R S Bresalier, S B Howell, C R Boland. Gastroenterology 1999
344
9

Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.
Yasushi Hamaya, Carla Guarinos, Stephanie S Tseng-Rogenski, Moriya Iwaizumi, Ritabrata Das, Rodrigo Jover, Antoni Castells, Xavier Llor, Montserrat Andreu, John M Carethers. PLoS One 2015
33
27

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.
Paul Lochhead, Aya Kuchiba, Yu Imamura, Xiaoyun Liao, Mai Yamauchi, Reiko Nishihara, Zhi Rong Qian, Teppei Morikawa, Jeanne Shen, Jeffrey A Meyerhardt,[...]. J Natl Cancer Inst 2013
306
9

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
J Goldstein, B Tran, J Ensor, P Gibbs, H L Wong, S F Wong, E Vilar, J Tie, R Broaddus, S Kopetz,[...]. Ann Oncol 2014
169
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.